ABSTRACT
Differentiated thyroid cancer in childhood is rare. Although its clinical course is quite aggressive with higher rates of lymph node and pulmonary metastases as compared to adults, the final outcome tends to be favorable. This is a review of the clinical picture, response to treatment and follow-up of differentiated thyroid cancer in children and young adolescents with main differences than adult differentiated thyroid cancer.
References
1
Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review. 1975-2014 Bethsda, MD: National Cancer Institude, 2014.
2
Parisi MT, Eslamy H, Mankoff D. Management of Differentiated Thyroid Cancer in Children: Focus on the American Thyroid Association Pediatric Guidelines. Semin Nucl Med 2016;46:147-164.
3
Howlader N, Noone AM, Krapcho M, et al. (Eds.) SEER Cancer Statistics Review, 1975–2016; National Cancer Institute: Bethesda, MD, USA, 2019.
4
Hogan AR, Zhuge Y, Perez EA, Koniaris LG, Lew JI, Sola JE. Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients. J Surg Res 2009;156:167-172.
5
Dionigi G, Kraimps JL, Schmid KW, et al. Minimally invasive follicular thyroid cancer (MIFTC)--a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbecks Arch Surg 2014;399:165-184.
6
Ito Y, Hirokawa M, Masuoka H, et al. Prognostic factors of minimally invasive follicular thyroid carcinoma: extensive vascular invasion significantly affects patient prognosis. Endocr J 2013;60:637-642.
7
Penta L, Cofini M, Lanciotti L, Leonardi A, Principi N, Esposito S. Hashimoto’s Disease and Thyroid Cancer in Children: Are They Associated Front. Endocrinol 2018;9:565.
8
Ahn HS, Auvinen A, Bauer AJ, et al. Thyroid health monitoring after nuclear accidents. Lyon France WHO, 2018;1-129.
9
Clement SC, van Eck-Smit BL, van Trotsenburg AS, Kremer LC, Tytgat GA, van Santen HM. Long-term follow-up of the thyroid gland after treatment with 131I-Metaiodobenzylguanidine in children with neuroblastoma: importance of continuous surveillance. Pediatr Blood Cancer 2013;60:1833-1838.
10
Meadows AT, Friedman DL, Neglia JP, et al. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol 2009;27:2356-2362.
11
Ron E, Lubin JH, Shore RE, et al. Thyroid cancer after exposure to external radiation a pooled analysis of 7 studies. Radiat Res 1995;141:259-277.
12
Veiga LH, Lubin JH, Anderson H, et al. A pooled analysis of thyroid cancer incidence following radiotherapy for childhood cancer. Radiat Res 2012;178:365-376.
13
Capezzone M, Marchisotta S, Cantara S, et al. Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. Endocr Relat Cancer 2008;15:1075-1081.
14
Martayan A, Sanchez-Mete L, Baldelli R, et al. Gene variants associated to malignant thyroid disease in familial adenomatous polyposis: a novel APC germline mutation. J Endocrinol Invest 2010;33:603-606.
15
Tan MH, Mester JL,14 Ngeow J, Rybicki LA, Orloff MS, Eng C. Life time cancer risks in individuals with germline PTENmutations. Clin Cancer Res 2012;18:400-407.
16
Stewart DR, Best AF, Williams GM, et al. Neoplasm Risk Among Individuals with a Pathogenic Germline Variant in DICER1. J Clin Oncol 2019;37:668-676.
17
Bauer AJ. Molecular Genetics of Thyroid Cancer in Children and Adolescents. Endocrinol Metab Clin North Am 2017;46:389-403.
18
Paulson VA, Rudzinski ER, Hawkins DS. Thyroid Cancer in the Pediatric Population. Genes (Basel) 2019;10:723.
19
Ly S, Frates MC, Benson CB, et al. Features and Outcome of Autonomous Thyroid Nodules in Children: 31 Consecutive Patients Seen at a Single Center. J Clin Endocrinol Metab 2016;101:3856-3862.
20
Francis GL, Waguespack SG, Bauer AJ, et al. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2015;25:716-759.
21
Tuttle RM, Haugen B, Perrier ND. Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why? Thyroid 2017;27:751-756.
22
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016;26:1-133.
23
Martinez-Rios C, Daneman A, Bajno L, van der Kaay DCM, Moineddin R, Wasserman JD. Utility of adult-based ultrasound malignancy risk stratifications in pediatric thyroid nodules. Pediatr Radiol 2018;48:74-84.
24
Lim-Dunham JE, Toslak IE, Reiter MP, Martin B. Assessment of the American College of Radiology Thyroid Imaging Reporting and Data System for Thyroid Nodule Malignancy Risk Stratification in a Pediatric Population. AJR Am J Roentgenol 2019;212:188-194.
25
Jatana KR, Zimmerman D. Pediatric thyroid nodules and malignancy. Otolaryngol Clin North Am 2015;48:47-58.
26
Niedziela M, Breborowicz D, Trejster E, Korman E. Hot nodules in children and adolescents in western Poland from 1996 to 2000: clinical analysis of 31 patients. J Pediatr Endocrinol Metab 2002;15:823-830.
27
Ali SZ, Cibas E. The Bethesda System for Reporting Thyroid Cytopathology: Definitions Criteria and Explanatory Notes. New York, Springer 2010.
28
Monaco SE, Pantanowitz L, Khalbuss WE, et al. Cytomorphological and molecular genetic findings in pediatric thyroid fine-needle aspiration. Cancer Cytopathol 2012;120:342-350.
29
Buryk MA, Monaco SE, Witchel SF, et al. Preoperative cytology with molecular analysis to help guide surgery for pediatric thyroid nodules. Int J Pediatr Otorhinolaryngol 2013;77:1697-1700.
30
Baumgarten HD, Bauer AJ, Isaza A, Mostoufi-Moab S, Kazahaya K, Adzick NS. Surgical management of pediatric thyroid disease: Complication rates after thyroidectomy at the Children’s Hospital of Philadelphia high-volume Pediatric Thyroid Center. J Pediatr Surg 2019;54:1969-1975.
31
Yeh MW, Bauer AJ, Bernet VA, et al. American Thyroid Association statement on preoperative imaging for thyroid cancer surgery. Thyroid 2015;25:3-14.
32
Baumgarten H, Jenks CM, Isaza A, et al. Bilateral papillary thyroid cancer in children: Risk factors and frequency of postoperative diagnosis. J Pediatr Surg 2020;55:1117-1122.
33
Hay ID, Gonzalez-Losada T, Reinalda MS, Honetschlager JA, Richards ML, Thompson GB. Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008. World J Surg 2010;34:1192-1202.
34
Lin JD, Chao TC, Chen ST, Huang YY, Liou MJ, Hsueh C. Operative strategy for follicular thyroid cancer in risk groups stratified by pTNM staging. Surg Oncol 2007;16:107-113.
35
Lazar L, Lebenthal Y, Segal K, et al. Pediatric Thyroid Cancer: Postoperative Classifications and Response to Initial Therapy as Prognostic Factors. J Clin Endocrinol Metab 2016;101:1970-1979.
36
Pires BP, Alves PA Jr, Bordallo MA, et al. Prognostic Factors for Early and Long-Term Remission in Pediatric Differentiated Thyroid Carcinoma: The Role of Sex, Age, Clinical Presentation, and the Newly Proposed American Thyroid Association Risk Stratification System. Thyroid 2016;26:1480-1487.
37
Lee JI, Chung YJ, Cho BY, Chong S, Seok JW, Park SJ. Postoperative-stimulated serum thyroglobulin measured at the time of 131I ablation is useful for the prediction of disease status in patients with differentiated thyroid carcinoma. Surgery 2013;153:828-835.
38
Brink JS, van Heerden JA, McIver B, et al. Papillary thyroid cancer with pulmonary metastases in children: long-term prognosis. Surgery 2000;128:881-886.
39
Jarzab B, Handkiewicz-Junak D, Wloch J. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review. Endocr Relat Cancer 2005;12:773-803.
40
Biko J, Reiners C, Kreissl MC, Verburg FA, Demidchik Y, Drozd V. Favourable course of disease after incomplete remission on (131)I therapy in children with pulmonary metastases of papillary thyroid carcinoma: 10 years follow-up. Eur J Nucl Med Mol Imaging 2011;38:651-655.
41
Lassmann M, Hänscheid H, Verburg FA, Luster M. The use of dosimetry in the treatment of differentiated thyroid cancer. Q J Nucl Med Mol Imaging 2011;55:107-115.
42
Lau WF, Zacharin MR, Waters K, Wheeler G, Johnston V, Hicks RJ. Management of paediatric thyroid carcinoma: recent experience with recombinant human thyroid stimulating hormone in preparation for radioiodine therapy. Intern Med J 2006;36:564-570.
43
Rivkees SA, Mazzaferri EL, Verburg FA, et al. The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy. Endocr Rev 2011;32:798-826.
44
Rubino C, de Vathaire F, Dottorini ME, et al. Second primary malignancies in thyroid cancer patients. Br J Cancer 2003;89:1638-1644.
45
Vini L, Hyer S, Al-Saadi A, Pratt B, Harmer C. Prognosis for fertility and ovarian function after treatment with radioiodine for thyroid cancer. Postgrad Med J 2002;78:92-93.
46
Wallace WH. Oncofertility and preservation of reproductive capacity in children and young adults. Cancer 2011;117:2301-2310.
47
Pazaitou-Panayiotou K, Iliadou PK, Mandanas S, et al. Papillary thyroid carcinomas in patients under 21 years of age: clinical and histologic characteristics of tumors ≤10 mm. J Pediatr 2015;166:451-456.
48
Hay ID, Lee RA, Davidge-Pitts C, Reading CC, Charboneau JW. Long-term outcome of ultrasound-guided percutaneous ethanol ablation of selected “recurrent” neck nodal metastases in 25 patients with TNM stages III or IVA papillary thyroid carcinoma previously treated by surgery and 131I therapy. Surgery 2013;154:1448-1454.
49
Kim SY, Kim SM, Chang H, et al. Long-term outcomes of ethanol injection therapy for locally recurrent papillary thyroid cancer. Eur Arch Otorhinolaryngol 2017;274:3497-3501.
50
Pawelczak M, David R, Franklin B, Kessler M, Lam L, Shah B. Outcomes of children and adolescents with well-differentiated thyroid carcinoma and pulmonary metastases following ¹³¹I treatment: a systematic review. Thyroid 2010;20:1095-1101.
51
Berdelou A, Lamartina L, Klain M, Leboulleux S, Schlumberger M. Treatment of refractory thyroid cancer. Endocr Relat Cancer 2018;25:209-223.
52
Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228-247.
53
Rao SN, Cabanillas ME. Navigating Systemic Therapy in Advanced Thyroid Carcinoma: From Standard of Care to Personalized Therapy and Beyond. J Endocr Soc 2018;2:1109-1130.
54
Mahajan P, Dawrant J, Kheradpour A, et al. Response to Lenvatinib in Children with Papillary Thyroid Carcinoma. Thyroid 2018;28:1450-1454.
55
Waguespack SG, Sherman SI, Williams MD, Clayman GL, Herzog CE. The successful use of sorafenib to treat pediatric papillary thyroid carcinoma. Thyroid 2009;19:407-412.